Etiology of community-acquired pneumonia in children of Barnaul
https://doi.org/10.25789/YMJ.2025.90.18
Abstract
The results of a survey of 1,118 Barnaul children aged 0 to 17 to determine the etiological structure of community-acquired pneumonia pathogens from January to October 2024 are presented. Mycoplasma pneumoniae was the predominant pathogen 36%, less often COVID-19. The clinical picture of mycoplasma pneumonia in children is atypical. Etiotropic therapy brings good results.
About the Authors
Yu. R. Fionova
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
Yu. F. Lobanov
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
V. S. Ponomarev
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
L. A. Strozenko
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
N. A. Dorokhov
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
I. Yu. Boldenkova
Алтайский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Briko N.I., Korshunova V.A., Lomonosova K. S. «Pneumococcal infection in the Russian Federation: the state of the problem» // Bulletin of the Russian Academy of Medical Sciences. 2021. No. 1. P. 28-42. doi: 10.15690/vramn1404.
2. Extrapulmonary manifestations of Mycoplasma pneumoniae infection in children/ N. I. Kolganova, D. Yu. Ovsyannikova, A. E. Andzhelya [et al.] // Childhood infections. 2024. No. 2. From 45-51. doi:10.22627/2072-8107-2024-23-2-45-51.
3. Zaitseva S.V., Zastrozhina A.K., Murtazaeva O.A. Mycoplasma infection in children (literature review) // Russian Medical Journal. 2017. No. 5. P. 327-334.
4. Clinic, diagnosis and treatment of respiratory Mycoplasma pneumoniae infection in children/A.L. Zaplatnikova, A.A Girina., I.D. Maikova [et al.] // Medical Council. 2019. No.17. P. 91-98. doi: 10.21518/2079-701X-2019-17-91-98.
5. Clinical, epidemiological and laboratory characteristics of mycoplasma infection in children /O.N. Lesina, Zh.N. Karneeva, E.O. Shishova [et al.] // Infectious diseases: News. Opinions. Training. 2016. No. 3. P. 49-53.
6. Koshkarina E.A., Kvashnina D.V., Shirokova I.Yu. Clinical, epidemiological and immunological characteristics of mycoplasma pneumonias (analytical review) // Medial 2019. No.1. P. 7-18. doi:10.21145/2225−0026−2019−1−7−18.
7. Working classification of the main clinical forms of bronchopulmonary diseases in children/ N.A. Geppe, N.N. Rozinova, I.K. Volkov, [et al.] // Practical medicine. 2010. No. 45. P. 93-97.
8. Russian Respiratory Society; Interregional Pediatric Respiratory Society; Federation of Pediatricians of the CIS countries; Moscow Society of Pediatricians. Community-acquired pneumonia in children. Clinical recommendations. Moscow: Original layout; 2015. P. 64
9. What do we know about mycoplasma pneumonia?/s.A. Rachina, O.A. Kupryushina, A.S. Yasneva [et al.] // Practical pulmonology. 2023. No. 3. P. 20-30. doi: 10.24412/2409-6636-2023-13021
10. Eidelstein I.A. «Mycoplasma pneumoniae − modern data on the structure, molecular biology and epidemiology of the pathogen» // Clinical microbiology and antimicrobial chemotherapy (CMAX). 2023. Vol. 25. No. 4. P. 332-349. doi: 10.36488/cmac.2023.4.332-349.
11. Bradley J.S., Byington C.L., Shah S.S. et al. Executive summary: the management of community-acquired pneumonia in infants and children older than months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America., Clin. Infec.t Dis., 2011. No. 53(7). P. 617-30. doi: 10.1093/cid/cir625.
Review
For citations:
Fionova Yu.R., Lobanov Yu.F., Ponomarev V.S., Strozenko L.A., Dorokhov N.A., Boldenkova I.Yu. Etiology of community-acquired pneumonia in children of Barnaul. Yakut Medical Journal. 2025;(2):85-88. https://doi.org/10.25789/YMJ.2025.90.18
Views:
26
Email this article 